Triple-negative breast cancer is a subtype of breast cancer characterized by the absence of three common receptors: estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). This type of cancer tends to be more aggressive and has fewer targeted treatment options compared to other breast cancer subtypes.